Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044212 · ClinicalTrials.gov registry record · NA
Bowel Function After Minimally Invasive Urogynecologic Surgery
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT01044212 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 72 participants.
The verdict
NCT01044212, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.
Interventions
- DRUG Docusate
- DRUG Bowel medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044212
The ClinicalTrials.gov registry entry for NCT01044212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Docusate is the first listed.
NCT01044212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044212 about?
NCT01044212 is a clinical study titled "Bowel Function After Minimally Invasive Urogynecologic Surgery". The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic surgery.
What is the current status of trial NCT01044212?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2009-11. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01044212?
The interventions under investigation include: Docusate (DRUG), Bowel medications (DRUG).
Who is sponsoring clinical trial NCT01044212?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.